World Health Organization

Long-lasting glaucoma fix? They can see it from here

By GREGORY ZELLER // A Stony Brook biotech looking to carve a nanotech niche in the science of glaucoma treatment is eyeing some impressive laboratory results. Sustained Nano Systems, working closely with Stony Brook University’s Center for Biotechnology, has “achieved positive in-vitro results on long-term sustained delivery of Latanaprost for glaucoma treatment,” according to a company statement. Decoded: The biotech can keep the No. 1 glaucoma drug ticking for 159 days in in-vitro tests, which…


No. 267: On good fellows, spoon benders, Octomoms and trends to come

Welcome, dear readers: And over the year’s penultimate hump we go. Just five more days until Christmas and 11 until tumultuous 2017 runs its course. Boy, have you earned a holiday. The Innovate LI team will be catching up on baking, last-minute shopping and gift-wrapping, so watch for our next newsletter on Dec. 27. We hope you enjoy a peaceful, safe and joyous weekend! Before there was Octomom: When Nadya Suleman famously gave birth to…


NIH grant links LI researcher to top diabetes study

By GREGORY ZELLER // A multiyear federal grant will plug a top Long Island researcher into medical science’s foremost diabetes study. Alan Jacobson, chief research officer at Mineola-based NYU Winthrop Hospital, has secured a $4.23 million stipend from the National Institutes of Health to study the long-term neurocognitive effects of type 1 diabetes. The five-year grant will help Jacobson better understand how the disease – which affects more than 1.25 million Americans, according to the…